Please assess the completion status of the following clinical trial:

Trial Title: Helicobacter Eradication Relief of Dyspeptic Symptoms

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients with more than 18 years~* Functional dyspepsia accordingly Rome III criteria~* Helicobacter pylori infection by two diagnostic tests~Exclusion Criteria:~* No concordance with informed consent~* Pregnant woman or breast feeding or no trust anticonceptional method~* Structural gastrointestinal abnormalities except gastritis, duodenitis or hiatal hernia~* Previous treatment for Helicobacter pylori infection~* Previous surgery on esophagus, stomach or duodenum~* Hypersensitivity to the drugs in study~* Proton pump inhibitor use in the previous 15 days~* H2-antagonists use in the previous 07 days~* Antibiotics use in the previous 30 days~* Patients unable to answer the study questionnaires~* Alcohol abuse~* Drug use~* Serious comorbidities~* Biliary colic~* Irritable bowel syndrome~* Gastroesophageal Reflux Disease

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): Amoxicillin 1000 mg BID, clarythromycin 500 mg BID and Omeprazole 20 mg BID for ten days
- 2 (Type: PLACEBO_COMPARATOR): Placebo of Amoxicillin 1000 mg BID, placebo of clarythromycin 500 mg BID and Omeprazole 20 mg BID for ten days

Based on this trial design, predict the completion outcome and termination type (if applicable).